Skip to main content
Ozempic® (Semaglutide), Victoza® (Liraglutide): GLP-1 Receptor Agonists Supply Shortage in the UK- Updates for Prescribers
For Healthcare Professionals
Novo Nordisk is experiencing supply shortages for the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the UK:
- Ozempic 0.25 mg, 0.5 mg, 1 mg solution for injection in pre-filled pen (semaglutide)
- Victoza 6mg/ml solution for injection in pre-filled pen (liraglutide)
